Baclofen Deal Offers Amneal Biosimilars Advantage

Firm Accelerates Biosimilars Schedule, With Three Launches Now Planned For This Year

 
• By Dave Wallace
  
Three rockets launch clouds space
Three biosimilar launches are planned this year for Amneal • Source: Emilija Randjelovic / Alamy Stock Vector

More from Deals

More from Business